Relative Bioavailability Study of Subcutaneous Injection Versus Intravenous Infusion of Pembrolizumab in Participants With Advanced Melanoma
The purpose of this study is to characterize the pharmacokinetic (PK) profile of pembrolizumab (MK-3475) following single subcutaneous (SC) injection of pembrolizumab Dose A versus pembrolizumab Dose C in adults with